Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

ALX ONCOLOGY HOLDINGS INC (ALXO) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 8-K Quarterly results
Docs: "ALX Oncology Reports Second Quarter 2023 Financial Results and Provides Clinical Program Update Advancing Phase 2/3 ASPEN-06 gastric cancer trial with data update expected in Q423 Terminating azacitidine combination development programs: ASPEN-02 in MDS and ASPEN-05 in AML Continuing focus on combinations with anti-cancer antibodies, antibody-drug conjugates, and PD-1/PD-L1 immune checkpoint inhibitors SOUTH SAN FRANCISCO, Calif., August 10, 2023 --"
05/11/2023 8-K Quarterly results
Docs: "ALX Oncology Reports First Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights SOUTH SAN FRANCISCO, Calif., May 11, 2023 --"
03/09/2023 8-K Quarterly results
Docs: "ALX Oncology Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones SOUTH SAN FRANCISCO, Calif., March 9, 2023 --"
11/08/2022 8-K Quarterly results
08/08/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
Docs: "Investor Contact:"
02/28/2022 8-K Quarterly results
11/12/2021 8-K Quarterly results
Docs: ", Calif., November 11, 2021"
08/12/2021 8-K Quarterly results
05/17/2021 8-K Quarterly results
03/18/2021 8-K Quarterly results
11/12/2020 8-K Quarterly results
Docs: "ALX Oncology Reports Third Quarter 2020 Financial Results and Provides Clinical Development and Operational Highlights"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy